A Phosphoproteomic Comparison of B-RAFV600Eand MKK1/2 Inhibitors in Melanoma Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phosphoproteomic Comparison of B-RAFV600Eand MKK1/2 Inhibitors in Melanoma Cells
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 14, Issue 6, Pages 1599-1615
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-04-08
DOI
10.1074/mcp.m114.047233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition
- (2014) R. Parker et al. MOLECULAR CANCER THERAPEUTICS
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using Ellipses
- (2014) Luana Micallef et al. PLoS One
- Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3
- (2014) J. A. Galan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Intersection of Immune-Directed and Molecularly Targeted Therapy in Advanced Melanoma: Where We Have Been, Are, and Will Be
- (2013) R. J. Sullivan et al. CLINICAL CANCER RESEARCH
- Resistance to RAF Inhibitors Revisited
- (2013) Edward Hartsough et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rapid Combinatorial ERLIC–SCX Solid-Phase Extraction for In-Depth Phosphoproteome Analysis
- (2013) Mostafa Zarei et al. JOURNAL OF PROTEOME RESEARCH
- Multidimensional separation of tryptic peptides from human serum proteins using reversed-phase, strong cation exchange, weak anion exchange, and fused-core fluorinated stationary phases
- (2013) Alexander P. Boichenko et al. JOURNAL OF SEPARATION SCIENCE
- Evolution and functional cross-talk of protein post-translational modifications
- (2013) Pedro Beltrao et al. Molecular Systems Biology
- Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions
- (2013) M. Courcelles et al. Molecular Systems Biology
- Large-scale gene function analysis with the PANTHER classification system
- (2013) Huaiyu Mi et al. Nature Protocols
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- Systematic Functional Prioritization of Protein Posttranslational Modifications
- (2012) Pedro Beltrao et al. CELL
- Combinatorial Use of Electrostatic Repulsion-Hydrophilic Interaction Chromatography (ERLIC) and Strong Cation Exchange (SCX) Chromatography for In-Depth Phosphoproteome Analysis
- (2012) Mostafa Zarei et al. JOURNAL OF PROTEOME RESEARCH
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- MEK1/2 dual-specificity protein kinases: Structure and regulation
- (2011) Robert Roskoski BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antagonistic TSC22D1 variants control BRAFE600-induced senescence
- (2011) Cornelia Hömig-Hölzel et al. EMBO JOURNAL
- Comparison of ERLIC–TiO2, HILIC–TiO2, and SCX–TiO2for Global Phosphoproteomics Approaches
- (2011) Mostafa Zarei et al. JOURNAL OF PROTEOME RESEARCH
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse
- (2011) P. V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- Large-Scale Discovery of ERK2 Substrates Identifies ERK-Mediated Transcriptional Regulation by ETV3
- (2011) S. M. Carlson et al. Science Signaling
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses
- (2010) J. T. Tigno-Aranjuez et al. GENES & DEVELOPMENT
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTOV1 is overexpressed in human high-grade malignant tumors
- (2010) Sara Fernández et al. VIRCHOWS ARCHIV
- Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics
- (2009) Cuiping Pan et al. MOLECULAR & CELLULAR PROTEOMICS
- Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
- (2009) William M. Old et al. MOLECULAR CELL
- The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis
- (2009) Yiguo Wang et al. NATURE
- Universal sample preparation method for proteome analysis
- (2009) Jacek R Wiśniewski et al. NATURE METHODS
- Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport
- (2009) Hidetaka Kosako et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Up-regulation of Mcl-1 Is Critical for Survival of Human Melanoma Cells upon Endoplasmic Reticulum Stress
- (2008) C. C. Jiang et al. CANCER RESEARCH
- The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel
- (2008) N. K. Haass et al. CLINICAL CANCER RESEARCH
- A Comparative Study of Electrostatic Repulsion-Hydrophilic Interaction Chromatography (ERLIC) versus SCX-IMAC-Based Methods for Phosphopeptide Isolation/Enrichment
- (2008) Chee Sian Gan et al. JOURNAL OF PROTEOME RESEARCH
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now